Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

N-Nitrosodibutylamine

N-Nitrosodibutylamine (N-Nitroso-di-n-butylamine) is a nitrosamine enriched in the drinking water. N-Nitrosodibutylamine regulates caspase pathway. N-Nitrosodibutylamine induces Apoptosis. N-Nitrosodibutylamine induces hepatocarcinoma and oxidative DNA damage[1][2][3][4][5].

Product Specifications

CAS Number

[924-16-3]

Product Name Alternative

N-Nitroso-di-n-butylamine

UNSPSC

12352211

Hazard Statement

H302, H351

Target

Apoptosis; Caspase

Type

Reference compound

Related Pathways

Apoptosis

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/n-nitrosodibutylamine.html

Concentration

10mM

Purity

99.96

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CCCCN(CCCC)N=O

Molecular Formula

C8H18N2O

Molecular Weight

158.24

Precautions

H302, H351

References & Citations

[1]Chao Zhao, et al. Distribution of N-nitrosamines in Drinking Water and Human Urinary Excretions in High Incidence Area of Esophageal Cancer in Huai'an, China. Chemosphere. 2019 Nov;235:288-296.|[2]García A, et al. N-Nitrosopiperidine and N-Nitrosodibutylamine induce apoptosis in HepG2 cells via the caspase dependent pathway. Cell Biol Int. 2009 Dec;33 (12) :1280-6.|[3]García A, et al. Organosulfur compounds alone or in combination with vitamin C protect towards N-nitrosopiperidine- and N-nitrosodibutylamine-induced oxidative DNA damage in HepG2 cells. Chem Biol Interact. 2008 May 9;173 (1) :9-18.|[4]Brittebo EB, et al. Tissue-specificity of N-nitrosodibutylamine metabolism in Sprague-Dawley rats. Chem Biol Interact. 1982 Jan;38 (2) :231-42.|[5]Dutta S P, et al. Effects of N-Nitrosodibutylamine on the liver mitochondria morphology and on the expression of liver mitochondrial membrane surface proteins in mice. International Journal of Pharmacy and Pharmaceutical Sciences, (8), 2016: 162-168.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Lentiviral human EDA2R shRNA (UAS) - Lentiviral human EDA2R shRNA (UAS, GFP) plasmid
GTR15153382 1 Vial

Lentiviral human EDA2R shRNA (UAS) - Lentiviral human EDA2R shRNA (UAS, GFP) plasmid

Sign In for Pricing
View Details
Lentiviral human POLR1B shRNA (UAS) - Lentiviral human POLR1B shRNA (UAS, iRFP) (25)
GTR15327689 1 Vial

Lentiviral human POLR1B shRNA (UAS) - Lentiviral human POLR1B shRNA (UAS, iRFP) (25)

Sign In for Pricing
View Details
Recombinant Campylobacter Jejuni sucC Protein (aa 1-387) (strain 81-176)
VAng-Ly2951-50gEcoli 50 µg (E. coli)

Recombinant Campylobacter Jejuni sucC Protein (aa 1-387) (strain 81-176)

Sign In for Pricing
View Details
HLA-DQW1 (Human Leukocyte Antigen DQW1) discontinued
376390 500 µg

HLA-DQW1 (Human Leukocyte Antigen DQW1) discontinued

Sign In for Pricing
View Details
FAF1 (FAS-associated Factor 1, hFAF1, UBX Domain-containing Protein 12, UBX Domain-containing Protein 3A, UBXD12, UBXN3A, CGI-03, FLJ37524)
126574 100 µg

FAF1 (FAS-associated Factor 1, hFAF1, UBX Domain-containing Protein 12, UBX Domain-containing Protein 3A, UBXD12, UBXN3A, CGI-03, FLJ37524)

Sign In for Pricing
View Details
Recombinant Escherichia coli O157:H7 Peptide chain release factor 3 (prfC)
MBS1227949-01 0.02 mg (E-Coli)

Recombinant Escherichia coli O157:H7 Peptide chain release factor 3 (prfC)

Sign In for Pricing
View Details